Skip to main content
. 2016 Oct 24;11(10):e0164515. doi: 10.1371/journal.pone.0164515

Fig 4. Pharmacokinetics of 6jc48-1 in vivo.

Fig 4

Compound was administered at 2.5 mg/kg (IV) or 5 mg/kg (PO) to male CD1 mice (n = 3) in 10% DMSO and 50% PEG 400 in PBS. Half-life was determined by measuring the plasma concentration of compound by LC/MS/MS at the time points indicated.